Ultragenyx Pharmaceutical said federal regulators have issued a complete response letter to its application for a metabolic disorder treatment that may delay the potential approval to 2026.

Aerobic exercise and a high capacity for exercise may protect against metabolic dysfunction-associated steatotic liver disease (MASLD), also known as fatty liver disease, by increasing the conversion ...

A bacterially produced molecule circulates in the bloodstream and increases the risk of cardiovascular disease by hijacking ...

Prediabetes is associated with a nearly 4-fold higher risk of MASLD. (1) Approximately 33% of Indian adults have prediabetes. (2) The burden of MASLD ...

Metabolic disorder, also referred to as metabolic syndrome, is a complex condition that presents itself in various forms. It is essentially a combination of health issues such as high blood pressure, ...